Will Radiation/Chemotherapy Treatment of Cervical Cancer Work Better With Medication That May Improve Anemia?
Status unconfirmed · Phase 2
Conditions studied: Anemia, Cervix Neoplasms
In brief
This is a clinical trial (a type of research study) designed to describe the efficacy (effectiveness) and toxicity (safety) of a new medical treatment, NESP (Novel Erythropoiesis Stimulating Protein). This study will be offered to patients with cervical cancer undergoing a combination of chemotherapy and radiation. This treatment may lower your red blood cells. The use of NESP may stimulate the body to produce more red blood cells. Our hypothesis is that higher red blood cells will be beneficial to the patient during treatment for cervical cancer.
Key facts
- Study ID
- NCT00039884
- Run by
- Mirhashemi, Ramin, M.D.
- People needed
- 64
- Starts
- 2001-09-01
- Expected to finish
- 2003-03-01
- Last updated by the study team
- 2005-06-24
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: accepted.
Where it is running
- Sylvester Comprehensive Cancer Center/JMH — Miami, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.